The latest Investing Matters Podcast episode featuring Jeremy Skillington, CEO of Poolbeg Pharma has just been released. Listen here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksRolls-Royce Regulatory News (RR.)

Share Price Information for Rolls-Royce (RR.)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 421.10
Bid: 420.00
Ask: 420.10
Change: 15.40 (3.80%)
Spread: 0.10 (0.024%)
Open: 411.70
High: 421.10
Low: 409.20
Prev. Close: 405.70
RR. Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Rolls-Royce Holdings plc AGM Statement

4 May 2017 07:00

RNS Number : 1110E
Rolls-Royce Holdings plc
04 May 2017
 

4 May 2017

 

 

ROLLS-ROYCE HOLDINGS PLC

AGM STATEMENT

 

Rolls-Royce Holdings plc is today holding its Annual General Meeting in Derby. In his comments to shareholders, Chief Executive Warren East will be confirming that overall trading in the first few months of the year has been in line with expectations and that the outlook for the year as a whole is unchanged. Reconfirming his comments in February at the Full Year Results, Warren East said: "At this early stage in the year we see no reason to change our expectations for profit and importantly cash flow for the year as a whole. We have some important transformation initiatives underway and, while we have made good progress in our cost cutting and efficiency programmes, more needs to be done to ensure we drive sustainable margin improvements within the business."

 

As in 2016, profit before financing charges and tax is expected to be weighted towards the second half of the year, with the proportion of profit generated in the first six months of the year expected to be similar to that achieved in 2016.

 

Similarly, free cash flow is again expected to be significantly weighted towards the second half with first half cash flow forecast to be lower than in 2016, largely reflecting the higher volumes of large engines sold at a loss and a number of other one-off cash items.

 

The 2017 outlook also excludes the year-on-year effect of foreign exchange translation on our reported results. Our guidance at this stage of the year is unchanged from that provided in February. If rates remain unchanged from those seen recently, the impact of the average year-on-year movement on the translation of our overseas subsidiaries results would improve reported revenues by around £400m and improve reported profit before tax by around £50m.

 

On April 19 it was announced that the European Commission had cleared the acquisition of the 53.1% shareholding in Industria de Turbo Propulsores SA ("ITP") currently owned by SENER Grupo de Ingeniería SA. Completion of the deal remains subject to approval by relevant Spanish authorities, expected later in 2017.

 

As set out in February the priorities for 2017 are fourfold: to strengthen our focus on engineering, operational and aftermarket excellence; to sustain our strong start to our transformation programme; to continue to rebuild trust and confidence in our long-term growth prospects; and, deliver an update on our long-term goals. In the first few months of the year we have sustained progress to deliver these priorities, including driving further benefits from our transformation programme. As a result, we remain on track to deliver the expected year-on-year incremental cost savings in 2017 of between £80-110m and achieve our target of £200m per annum by the end of 2017.

 

A more detailed update on progress towards our 2017 objectives will be given with our Half Year Results in August 2017.

 

 

For further information, please contact:

 

Investors:

John Dawson +44 7557 287101

Helen Harman +44 7968 906645

Ross Hawley +44 7920 822534

 

Media:

Richard Wray +44 7810 850055

 

 

This announcement contains forward-looking statements. Any statements that express forecasts, expectations and projections are not guarantees of future performance and will not be updated. By their nature, these statements involve risk and uncertainty, and a number of factors could cause material differences to the actual results or developments. This announcement is intended to provide information to shareholders, is not designed to be relied upon by any other party, or for any other purpose and the Company and its directors accept no liability to any other person other than under English law.

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
AGMUGUQGAUPMGQW
Date   Source Headline
26th Apr 20241:36 pmRNSDirector/PDMR Shareholding
10th Apr 20242:00 pmRNSDirector/PDMR Shareholding
10th Apr 20241:50 pmRNSHolding(s) in Company
2nd Apr 202410:00 amRNSDirector/PDMR Shareholding
26th Mar 202411:00 amRNSDirector/PDMR Shareholding
13th Mar 20249:00 amRNSDirector/PDMR Shareholding
8th Mar 20241:45 pmRNSDirector/PDMR Shareholding
6th Mar 20248:30 amRNSDirector/PDMR Shareholding
1st Mar 202411:30 amRNSDirector/PDMR Shareholding
29th Feb 20249:00 amRNSAGM Statement
28th Feb 20243:30 pmRNSDirector/PDMR Shareholding
23rd Feb 202410:30 amRNSDirector/PDMR Shareholding
22nd Feb 20247:00 amRNSFull Year Results 2023
8th Feb 20244:00 pmRNSDirector/PDMR Shareholding
26th Jan 20243:00 pmRNSDirector/PDMR Shareholding
10th Jan 202411:45 amRNSDirector/PDMR Shareholding
21st Dec 20232:00 pmRNSDirector/PDMR Shareholding
21st Dec 20231:58 pmRNSDirector/PDMR Shareholding
20th Dec 202310:00 amRNSHolding(s) in Company
11th Dec 20233:45 pmRNSHolding(s) in Company
8th Dec 202312:00 pmRNSDirector/PDMR Shareholding
1st Dec 20234:00 pmRNSTotal Voting Rights
1st Dec 20233:50 pmRNSDirector/PDMR Shareholding
1st Dec 20233:45 pmRNSDirector/PDMR Shareholding
29th Nov 20232:15 pmRNSDirector/PDMR Shareholding
29th Nov 20231:00 pmRNSDirector/PDMR Shareholding
28th Nov 20237:00 amRNSCapital Markets Day
8th Nov 202311:30 amRNSDirector/PDMR Shareholding
30th Oct 202310:15 amRNSDirector/PDMR Shareholding
17th Oct 20237:00 amRNSRolls-Royce creates more efficient organisation
11th Oct 20232:52 pmRNSDirector/PDMR Shareholding
3rd Oct 20239:30 amRNSHolding(s) in Company
28th Sep 202310:30 amRNSDirector/PDMR Shareholding
11th Sep 20239:30 amRNSDirector/PDMR Shareholding
25th Aug 20232:45 pmRNSDirector/PDMR Shareholding
8th Aug 202312:30 pmRNSDirector/PDMR Shareholding
8th Aug 20239:45 amRNSDirector/PDMR Shareholding
4th Aug 202311:51 amRNSHolding(s) in Company
3rd Aug 20237:00 amRNS2023 Half Year Results
2nd Aug 20237:00 amRNSDirectorate Change
31st Jul 20239:30 amRNSDirector/PDMR Shareholding
26th Jul 20237:00 amRNSTrading Update
20th Jul 20239:00 amRNSDirectorate Change
10th Jul 20233:30 pmRNSDirector/PDMR Shareholding
3rd Jul 20239:32 amRNSTotal Voting Rights
28th Jun 20233:30 pmRNSDirector/PDMR Shareholding
27th Jun 202312:00 pmRNSAdmission of Shares
8th Jun 20232:00 pmRNSDirector/PDMR Shareholding
30th May 202312:00 pmRNSDirector/PDMR Shareholding
19th May 202312:00 pmRNSDirector/PDMR Shareholding

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.